Regen BioPharma RGBP
OTC RGBP
$0.00 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Regen BioPharma Inc (RGBP) Current Deferred Revenue (2017 - 2025)

Updated

Regen BioPharma (RGBP) posted Current Deferred Revenue of $1.31 million for fiscal Q1 2026 (quarter ended Dec 31, 2025), down 8.8% from $1.43 million a year earlier and down 2.4% from the prior quarter.

Analysis

Regen BioPharma Inc (RGBP) Current Deferred Revenue (2017 - 2025) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Regen BioPharma's Current Deferred Revenue came in at $1.34 million, down 8.6% from FY2024.

  • In prior fiscal years, Regen BioPharma's Current Deferred Revenue was $1.47 million in FY2024 (-8.8%) and $1.61 million in FY2023.
  • The fiscal Q1 2026 figure stands as the lowest quarterly Current Deferred Revenue since fiscal Q3 2018.
  • According to Business Quant data, Current Deferred Revenue for the three prior fiscal quarters was $1.34 million (Q4 2025), $1.37 million (Q3 2025) and $1.4 million (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.31 Mn
Sep 30, 2025 1.34 Mn
Jun 30, 2025 1.37 Mn
Mar 31, 2025 1.40 Mn
Dec 31, 2024 1.43 Mn
Sep 30, 2024 1.47 Mn
Sep 30, 2023 1.61 Mn
Jun 30, 2021 1.88 Mn
Jun 30, 2018 68,000.00
Mar 31, 2018 168,000.00
Dec 31, 2017 58,000.00
API Access

Regen BioPharma Inc Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RGBP&period=max&api_key=YOUR_API_KEY